Mitra A - Search Results

1

microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.

Rostas JW 3rd, Pruitt HC, Metge BJ, Mitra A, Bailey SK, Bae S, Singh KP, Devine DJ, Dyess DL, Richards WO, Tucker JA, Shevde LA, Samant RS. Rostas JW 3rd, et al. Among authors: mitra a. Mol Cancer. 2014 Aug 29;13:200. doi: 10.1186/1476-4598-13-200. Mol Cancer. 2014. PMID: 25174825 Free PMC article.

2

Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.

Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA, Samant RS. Fillmore RA, et al. Among authors: mitra a. Int J Cancer. 2009 Aug 1;125(3):556-64. doi: 10.1002/ijc.24276. Int J Cancer. 2009. PMID: 19358268 Free article.

3

N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells.

Metge BJ, Mitra A, Chen D, Shevde LA, Samant RS. Metge BJ, et al. Among authors: mitra a. Sci Rep. 2015 Jul 6;5:11995. doi: 10.1038/srep11995. Sci Rep. 2015. PMID: 26146406 Free PMC article.

4

DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.

Mitra A, Menezes ME, Pannell LK, Mulekar MS, Honkanen RE, Shevde LA, Samant RS. Mitra A, et al. Oncogene. 2012 Oct 11;31(41):4472-83. doi: 10.1038/onc.2011.623. Epub 2012 Jan 23. Oncogene. 2012. PMID: 22266849 Free PMC article.

5

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS. Mitra A, et al. Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7. Breast Cancer Res. 2008. PMID: 18328103 Free PMC article.

6

NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.

Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O, Shevde LA. Clark DW, et al. Among authors: mitra a. Curr Cancer Drug Targets. 2008 Aug;8(5):421-30. doi: 10.2174/156800908785133196. Curr Cancer Drug Targets. 2008. PMID: 18690848

7

Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin.

Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J, King JA, Samant RS. Shevde LA, et al. Among authors: mitra a. J Cell Mol Med. 2010 Jun;14(6B):1693-706. doi: 10.1111/j.1582-4934.2009.00821.x. Epub 2009 Jun 16. J Cell Mol Med. 2010. PMID: 19538464 Free PMC article.

8

DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype.

Mitra A, Menezes ME, Shevde LA, Samant RS. Mitra A, et al. J Biol Chem. 2010 Aug 6;285(32):24686-94. doi: 10.1074/jbc.M109.094847. Epub 2010 Jun 3. J Biol Chem. 2010. PMID: 20522561 Free PMC article.

9

DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity.

Menezes ME, Mitra A, Shevde LA, Samant RS. Menezes ME, et al. Among authors: mitra a. Biochem J. 2012 Jun 15;444(3):573-80. doi: 10.1042/BJ20120205. Biochem J. 2012. PMID: 22455953 Free PMC article.

10

Micro-RNA-632 downregulates DNAJB6 in breast cancer.

Mitra A, Rostas JW, Dyess DL, Shevde LA, Samant RS. Mitra A, et al. Lab Invest. 2012 Sep;92(9):1310-7. doi: 10.1038/labinvest.2012.87. Epub 2012 Jun 18. Lab Invest. 2012. PMID: 22710984 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,582 results

Search Page